This method develops nanoparticle analysis in drug delivery, suggesting improved quality beyond standards.
Lipid-based nanoparticles (LNPs) are transforming the field of drug delivery, with one gene therapy product and four mRNA vaccines approved at the time of this report. As with other novel...
No takes yet. Share an insight, caveat, or question.
Abdulrahman et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: